Clearpoint Neuro, Inc. (CLPT) — 10-Q Filings
All 10-Q filings from Clearpoint Neuro, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
ClearPoint Neuro's Revenue Up, But Losses Widen Amid Investment
— Nov 6, 2025 Risk: high
ClearPoint Neuro, Inc. (CLPT) reported a mixed financial performance for the three and nine months ended September 30, 2025. Total revenue for the three months -
ClearPoint Neuro Revenue Jumps 21%, Net Loss Widens to $10.2M
— Aug 12, 2025 Risk: high
ClearPoint Neuro, Inc. reported a significant increase in revenue for the three months ended June 30, 2025, reaching $7.5 million, up from $6.2 million in the p -
ClearPoint Neuro Files Q1 2025 10-Q
— May 13, 2025 Risk: medium
ClearPoint Neuro, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and business operations, including revenue -
ClearPoint Neuro Q3 Sales Rise to $12.7M
— Nov 7, 2024 Risk: medium
ClearPoint Neuro, Inc. reported its third quarter 2024 results, with net sales reaching $12.7 million for the three months ended September 30, 2024, an increase -
ClearPoint Neuro Reports Q2 2024 Financials
— Aug 7, 2024 Risk: medium
ClearPoint Neuro, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported revenue from product sales and services, with specific figures f -
ClearPoint Neuro, Inc. Files 10-Q for Period Ending March 31, 2024
— May 7, 2024 Risk: low
ClearPoint Neuro, Inc. (CLPT) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. ClearPoint Neuro, Inc. filed a 10-Q report for the period ending Marc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX